Drug Treatment of Lipid Disorders
Authors:
- J DornJDJ Dorn
- J NaughtonJNJ Naughton
- C GallettiCGC Galletti
Open Access
- 23 December 1999
- journal article
- letter
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 341 (26) , 2020-2021
Abstract
In his review of drug treatment for lipid disorders (Aug. 12 issue),1 Dr. Knopp notes that dietary intervention is an important first step in the treatment of patients with hyperlipidemia. We would like to remind readers not to overlook the benefits of physical activity in such patients. In addition to raising serum high-density lipoprotein (HDL) cholesterol concentrations, physical activity facilitates weight loss and has also been reported to reduce the risk of cardiovascular diseases, an effect that is independent of its effects on serum lipid concentrations in both men and women. For these reasons, physical activity along with dietary modification is recommended as the first line of therapy in the second report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults.2Keywords
This publication has 11 references indexed in Scilit:
- Drug Treatment of Lipid DisordersNew England Journal of Medicine, 1999
- Gemfibrozil for the Secondary Prevention of Coronary Heart Disease in Men with Low Levels of High-Density Lipoprotein CholesterolNew England Journal of Medicine, 1999
- Serum homocysteine increases after therapy with fenofibrate or bezafibrateThe Lancet, 1999
- Fibrate-induced Renal Dysfunction: is Gemfibrozil the only Non-nephrotoxic Agent?Transplantation, 1999
- Lipid-lowering drugs and homocysteineThe Lancet, 1999
- Alternative Medicine — The Risks of Untested and Unregulated RemediesNew England Journal of Medicine, 1998
- Renal artery embolization after back massage in a patient with aortic occlusionNephrology Dialysis Transplantation, 1997
- Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)JAMA, 1993
- Modest changes in high-density lipoprotein concentration and metabolism with prolonged exercise training.Circulation, 1988
- Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with DyslipidemiaNew England Journal of Medicine, 1987